{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:19:15Z","timestamp":1793949555594,"version":"4.8.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000055","name":"NIDCD","doi-asserted-by":"publisher","award":["R01DC018562"],"award-info":[{"award-number":["R01DC018562"]}],"id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["1F31DK142526-01A1"],"award-info":[{"award-number":["1F31DK142526-01A1"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["R01DK104897"],"award-info":[{"award-number":["R01DK104897"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["R01DK123423"],"award-info":[{"award-number":["R01DK123423"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["biologicalpsychiatryjournal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.biopsych.2026.06.006","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:16:05Z","timestamp":1781885765000},"page":"850-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Glucagon-Like Peptide-1 Signaling in Learning and Memory: Evidence, Mechanisms, and Therapeutic Implications"],"prefix":"10.1016","volume":"100","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4235-6238","authenticated-orcid":false,"given":"Alexander G.","family":"Bashaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciorana","family":"Roman-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena X.","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey A.","family":"Schier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tito","family":"Borner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott E.","family":"Kanoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopsych.2026.06.006_bib1","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"Muller","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/j.biopsych.2026.06.006_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101090","article-title":"Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease","volume":"46","author":"Baggio","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.biopsych.2026.06.006_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.cmet.2006.01.004","article-title":"The biology of incretin hormones","volume":"3","author":"Drucker","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/j.biopsych.2026.06.006_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-nutr-071812-161201","article-title":"Incretins and amylin: Neuroendocrine communication between the gut, pancreas, and brain in control of food intake and blood glucose","volume":"34","author":"Hayes","year":"2014","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.biopsych.2026.06.006_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/j.2040-4603.2020.tb00123.x","article-title":"Glucagon-like peptide-1: Actions and influence on pancreatic hormone function","volume":"10","author":"Davis","year":"2020","journal-title":"Compr Physiol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2337\/db15-0973","article-title":"Knockdown of GLP-1 receptors in vagal afferents affects normal food intake and glycemia","volume":"65","author":"Krieger","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.biopsych.2026.06.006_bib7","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/en.2008-1221","article-title":"Intrameal hepatic portal and intraperitoneal infusions of glucagon-like peptide-1 reduce spontaneous meal size in the rat via different mechanisms","volume":"150","author":"Ruttimann","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopsych.2026.06.006_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s13195-024-01537-1","article-title":"Comparing regional brain uptake of incretin receptor agonists after intranasal delivery in CD-1 mice and the APP\/PS1 mouse model of Alzheimer\u2019s disease","volume":"16","author":"Abdulhameed","year":"2024","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.biopsych.2026.06.006_bib9","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.2337\/db17-1385","article-title":"Liraglutide modulates appetite and body weight through glucagon-like peptide 1 receptor-expressing glutamatergic neurons","volume":"67","author":"Adams","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/j.biopsych.2026.06.006_bib10","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1038\/npp.2016.246","article-title":"Endogenous glucagon-like peptide-1 receptor signaling in the nucleus tractus solitarius is required for food intake control","volume":"42","author":"Alhadeff","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.006_bib11","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.2337\/db09-0281","article-title":"Differences in the central anorectic effects of glucagon-like peptide-1 and exendin-4 in rats","volume":"58","author":"Barrera","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.biopsych.2026.06.006_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8071","article-title":"GABA neurons in the nucleus tractus solitarius express GLP-1 receptors and mediate anorectic effects of liraglutide in rats","volume":"12","author":"Fortin","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.biopsych.2026.06.006_bib13","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.133429","article-title":"Semaglutide lowers body weight in rodents via distributed neural pathways","volume":"5","author":"Gabery","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopsych.2026.06.006_bib14","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1210\/en.2007-1743","article-title":"Caudal brainstem processing is sufficient for behavioral, sympathetic, and parasympathetic responses driven by peripheral and hindbrain glucagon-like-peptide-1 receptor stimulation","volume":"149","author":"Hayes","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopsych.2026.06.006_bib15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.cmet.2011.02.001","article-title":"Intracellular signals mediating the food intake-suppressive effects of hindbrain glucagon-like peptide-1 receptor activation","volume":"13","author":"Hayes","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.biopsych.2026.06.006_bib16","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biopsych.2026.06.006_bib17","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1210\/en.2011-0174","article-title":"Peripheral and central GLP-1 receptor populations mediate the anorectic effects of peripherally administered GLP-1 receptor agonists, liraglutide and exendin-4","volume":"152","author":"Kanoski","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopsych.2026.06.006_bib18","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1172\/JCI72434","article-title":"Neuronal GLP1R mediates liraglutide\u2019s anorectic but not glucose-lowering effect","volume":"124","author":"Sisley","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biopsych.2026.06.006_bib19","doi-asserted-by":"crossref","first-page":"R885","DOI":"10.1152\/ajpregu.00520.2015","article-title":"GLP-1 and weight loss: Unraveling the diverse neural circuitry","volume":"310","author":"Kanoski","year":"2016","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib20","doi-asserted-by":"crossref","first-page":"14453","DOI":"10.1523\/JNEUROSCI.3262-11.2011","article-title":"Glucagon-like peptide 1 receptors in nucleus accumbens affect food intake","volume":"31","author":"Dossat","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.006_bib21","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1210\/en.2011-1443","article-title":"GLP-1 neurons in the nucleus of the solitary tract project directly to the ventral tegmental area and nucleus accumbens to control for food intake","volume":"153","author":"Alhadeff","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopsych.2026.06.006_bib22","doi-asserted-by":"crossref","first-page":"4812","DOI":"10.1523\/JNEUROSCI.6326-11.2012","article-title":"The glucagon-like peptide 1 (GLP-1) analogue, exendin-4, decreases the rewarding value of food: a new role for mesolimbic GLP-1 receptors","volume":"32","author":"Dickson","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.006_bib23","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1016\/j.neuropharm.2011.12.022","article-title":"The role of nausea in food intake and body weight suppression by peripheral GLP-1 receptor agonists, exendin-4 and liraglutide","volume":"62","author":"Kanoski","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.06.006_bib24","doi-asserted-by":"crossref","first-page":"383","DOI":"10.3389\/fnins.2018.00383","article-title":"Alzheimer\u2019s disease and type 2 diabetes: A critical assessment of the shared pathological traits","volume":"12","author":"Chatterjee","year":"2018","journal-title":"Front Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.006_bib25","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.biopsych.2015.09.011","article-title":"Hippocampus contributions to food intake control: Mnemonic, neuroanatomical, and endocrine mechanisms","volume":"81","author":"Kanoski","year":"2017","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2026.06.006_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neubiorev.2021.10.051","article-title":"Memory and eating: A bidirectional relationship implicated in obesity","volume":"132","author":"Parent","year":"2022","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.biopsych.2026.06.006_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13205-022-03123-4","article-title":"Hippocampus and its involvement in Alzheimer\u2019s disease: A review","volume":"12","author":"Rao","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.biopsych.2026.06.006_bib28","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.neuroimage.2005.12.033","article-title":"Changes in hippocampal connectivity in the early stages of Alzheimer\u2019s disease: Evidence from resting state fMRI","volume":"31","author":"Wang","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/j.biopsych.2026.06.006_bib29","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.neuroscience.2015.04.045","article-title":"Models and mechanisms for hippocampal dysfunction in obesity and diabetes","volume":"309","author":"Stranahan","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2026.06.006_bib30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fnagi.2014.00088","article-title":"Blood-brain barrier disruption: Mechanistic links between Western diet consumption and dementia","volume":"6","author":"Hsu","year":"2014","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.006_bib31","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3233\/JAD-2010-091414","article-title":"The effects of a high-energy diet on hippocampal function and blood-brain barrier integrity in the rat","volume":"21","author":"Kanoski","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2026.06.006_bib32","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm919","article-title":"Glucagon-like peptide-1 receptor is involved in learning and neuroprotection","volume":"9","author":"During","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.biopsych.2026.06.006_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/(SICI)1096-9861(19990111)403:2<261::AID-CNE8>3.0.CO;2-5","article-title":"Distribution of pre-pro-glucagon and glucagon-like peptide-1 receptor messenger RNAs in the rat central nervous system","volume":"403","author":"Merchenthaler","year":"1999","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib34","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/npp.2014.175","article-title":"Hippocampal GLP-1 receptors influence food intake, meal size, and effort-based responding for food through volume transmission","volume":"40","author":"Hsu","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2026.06.006_bib35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s00401-016-1662-x","article-title":"Alzheimer\u2019s disease: Experimental models and reality","volume":"133","author":"Drummond","year":"2017","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib36","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13024-024-00712-0","article-title":"Updates on mouse models of Alzheimer\u2019s disease","volume":"19","author":"Zhong","year":"2024","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.biopsych.2026.06.006_bib37","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1172\/JCI57256","article-title":"An anti-diabetes agent protects the mouse brain from defective insulin signaling caused by Alzheimer\u2019s disease-associated Abeta oligomers","volume":"122","author":"Bomfim","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.biopsych.2026.06.006_bib38","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.neuropharm.2017.11.048","article-title":"GLP-1 receptor agonists downregulate aberrant GnT-III expression in Alzheimer\u2019s disease models through the Akt\/GSK-3beta\/beta-catenin signaling","volume":"131","author":"Wang","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.06.006_bib39","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80388","article-title":"Obesogenic diet induces circuit-specific memory deficits in mice","volume":"13","author":"Bakoyiannis","year":"2024","journal-title":"Elife"},{"key":"10.1016\/j.biopsych.2026.06.006_bib40","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/hipo.22267","article-title":"Onset of hippocampus-dependent memory impairments in 5XFAD transgenic mouse model of Alzheimer\u2019s disease","volume":"24","author":"Girard","year":"2014","journal-title":"Hippocampus"},{"key":"10.1016\/j.biopsych.2026.06.006_bib41","article-title":"Semaglutide ameliorates diabetes-associated cognitive dysfunction in mouse model of type 2 diabetes","volume":"20","author":"Zhu","year":"2025","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2026.06.006_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.111932","article-title":"Exenatide alleviates mitochondrial dysfunction and cognitive impairment in the 5xFAD mouse model of Alzheimer\u2019s disease","volume":"370","author":"An","year":"2019","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2026.06.006_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2021.111529","article-title":"Glucagon-like peptide-1 analogs mitigate neuroinflammation in Alzheimer\u2019s disease by suppressing NLRP2 activation in astrocytes","volume":"542","author":"Zhang","year":"2022","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib44","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s12031-019-1257-9","article-title":"Combination of insulin with a GLP1 agonist is associated with better memory and normal expression of insulin receptor pathway genes in a mouse model of Alzheimer\u2019s disease","volume":"67","author":"Robinson","year":"2019","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.006_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.139","article-title":"Exenatide promotes cognitive enhancement and positive brain metabolic changes in PS1-KI mice but has no effects in 3xTg-AD animals","volume":"4","author":"Bomba","year":"2013","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.biopsych.2026.06.006_bib46","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1007\/s11064-017-2250-8","article-title":"Liraglutide improves water maze learning and memory performance while reduces hyperphosphorylation of tau and neurofilaments in APP\/PS1\/tau triple transgenic mice","volume":"42","author":"Chen","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1016\/j.biopsych.2026.06.006_bib47","doi-asserted-by":"crossref","first-page":"6587","DOI":"10.1523\/JNEUROSCI.0529-11.2011","article-title":"The diabetes drug liraglutide prevents degenerative processes in a mouse model of Alzheimer\u2019s disease","volume":"31","author":"McClean","year":"2011","journal-title":"J Neurosci"},{"issue":"pt A","key":"10.1016\/j.biopsych.2026.06.006_bib48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2013.08.005","article-title":"Liraglutide can reverse memory impairment, synaptic loss and reduce plaque load in aged APP\/PS1 mice, a model of Alzheimer\u2019s disease","volume":"76","author":"McClean","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.06.006_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158205","article-title":"Long-term treatment with liraglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, has no effect on beta-amyloid plaque load in two transgenic APP\/PS1 mouse models of Alzheimer\u2019s disease","volume":"11","author":"Hansen","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2026.06.006_bib50","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2015.07.024","article-title":"Prophylactic liraglutide treatment prevents amyloid plaque deposition, chronic inflammation and memory impairment in APP\/PS1 mice","volume":"293","author":"McClean","year":"2015","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2026.06.006_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109716","article-title":"Semaglutide ameliorates cognition and glucose metabolism dysfunction in the 3xTg mouse model of Alzheimer\u2019s disease via the GLP-1R\/SIRT1\/GLUT4 pathway","volume":"240","author":"Wang","year":"2023","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.06.006_bib52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/13872877251329439","article-title":"Semaglutide improves cognitive function and neuroinflammation in APP\/PS1 transgenic mice by activating AMPK and inhibiting TLR4\/NF-kappaB pathway","volume":"105","author":"Zhai","year":"2025","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2026.06.006_bib53","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1507\/endocrj.EJ23-0723","article-title":"Liraglutide improves cognition function in streptozotocin-induced diabetic rats by downregulating beta-secretase and gamma-secretase and alleviating oxidative stress in HT-22 cells","volume":"72","author":"Ma","year":"2025","journal-title":"Endocr J"},{"key":"10.1016\/j.biopsych.2026.06.006_bib54","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.4103\/1673-5374.160076","article-title":"Streptozotocin induced Alzheimer\u2019s disease like changes and the underlying neural degeneration and regeneration mechanism","volume":"10","author":"Kamat","year":"2015","journal-title":"Neural Regen Res"},{"key":"10.1016\/j.biopsych.2026.06.006_bib55","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s11357-011-9303-8","article-title":"Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer\u2019s disease by exendin-4","volume":"34","author":"Chen","year":"2012","journal-title":"Age (Dordr)"},{"key":"10.1016\/j.biopsych.2026.06.006_bib56","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3233\/JAD-130584","article-title":"The neuroprotection of liraglutide on Alzheimer-like learning and memory impairment by modulating the hyperphosphorylation of tau and neurofilament proteins and insulin signaling pathways in mice","volume":"37","author":"Xiong","year":"2013","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2026.06.006_bib57","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1007\/s12035-023-03698-w","article-title":"Exendin-4 prevents memory loss and neuronal death in rats with sporadic Alzheimer-like disease","volume":"61","author":"Zago","year":"2024","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib58","article-title":"Intracerebroventricular injection of amyloid-beta peptides in normal mice to acutely induce Alzheimer-like cognitive deficits","volume":"16","author":"Kim","year":"2016","journal-title":"J Vis Exp"},{"key":"10.1016\/j.biopsych.2026.06.006_bib59","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ejphar.2016.04.052","article-title":"Subcutaneous administration of liraglutide ameliorates learning and memory impairment by modulating tau hyperphosphorylation via the glycogen synthase kinase-3beta pathway in an amyloid beta protein induced Alzheimer disease mouse model","volume":"783","author":"Qi","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib60","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.neuint.2019.04.006","article-title":"Exendin-4 attenuates brain mitochondrial toxicity through PI3K\/Akt-dependent pathway in amyloid beta (1-42)-induced cognitive deficit rats","volume":"128","author":"Garabadu","year":"2019","journal-title":"Neurochem Int"},{"key":"10.1016\/j.biopsych.2026.06.006_bib61","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1002\/path.5056","article-title":"The diabetes drug liraglutide reverses cognitive impairment in mice and attenuates insulin receptor and synaptic pathology in a non-human primate model of Alzheimer\u2019s disease","volume":"245","author":"Batista","year":"2018","journal-title":"J Pathol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib62","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.physbeh.2016.03.016","article-title":"Exendin-4, a glucagon-like peptide 1 receptor agonist, protects against amyloid-beta peptide-induced impairment of spatial learning and memory in rats","volume":"159","author":"Jia","year":"2016","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2026.06.006_bib63","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.neurobiolaging.2012.04.009","article-title":"Liraglutide protects against amyloid-beta protein-induced impairment of spatial learning and memory in rats","volume":"34","author":"Han","year":"2013","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.biopsych.2026.06.006_bib64","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.neuroscience.2014.02.022","article-title":"Lixisenatide rescues spatial memory and synaptic plasticity from amyloid beta protein-induced impairments in rats","volume":"277","author":"Cai","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2026.06.006_bib65","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s40520-016-0548-z","article-title":"Intranasal administration of exendin-4 antagonizes Abeta31-35-induced disruption of circadian rhythm and impairment of learning and memory","volume":"28","author":"Wang","year":"2016","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/j.biopsych.2026.06.006_bib66","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/s41366-018-0240-9","article-title":"The effects of a GLP-1 analog liraglutide on reward value and the learned inhibition of appetitive behavior in male and female rats","volume":"43","author":"Jones","year":"2019","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.biopsych.2026.06.006_bib67","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.3390\/jcm13133729","article-title":"All GLP-1 agonists should, theoretically, cure Alzheimer\u2019s dementia but dulaglutide might be more effective than the others","volume":"13","author":"Fessel","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.biopsych.2026.06.006_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101470","article-title":"GLP-1 receptor agonists effect on cognitive function in patients with and without type 2 diabetes","volume":"49","author":"Monney","year":"2023","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.biopsych.2026.06.006_bib69","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fnagi.2016.00108","article-title":"In Alzheimer\u2019s disease, 6-month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial","volume":"8","author":"Gejl","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.006_bib70","first-page":"141","article-title":"12-month effects of incretins versus SGLT2-Inhibitors on cognitive performance and metabolic profile. A randomized clinical trial in the elderly with type-2 diabetes mellitus","volume":"10","author":"Perna","year":"2018","journal-title":"Clin Pharmacol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib71","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.bbr.2018.08.006","article-title":"Neural correlates of liraglutide effects in persons at risk for Alzheimer\u2019s disease","volume":"356","author":"Watson","year":"2019","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.biopsych.2026.06.006_bib72","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.2337\/dc18-2584","article-title":"Olfactory dysfunction mediates adiposity in cognitive impairment of type 2 diabetes: Insights from clinical and functional neuroimaging studies","volume":"42","author":"Zhang","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopsych.2026.06.006_bib73","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020734","article-title":"Activation of glucagon-like peptide-1 receptor ameliorates cognitive decline in type 2 diabetes mellitus through a metabolism-independent pathway","volume":"10","author":"Li","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.biopsych.2026.06.006_bib74","article-title":"Treatment with glucagon-like peptide-1 receptor agonists and incidence of dementia: data from pooled double-blind randomized controlled trials and nationwide disease and prescription registers","volume":"8","author":"Norgaard","year":"2022","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.1016\/j.biopsych.2026.06.006_bib75","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/s41366-020-0535-5","article-title":"Liraglutide improves memory in obese patients with prediabetes or early type 2 diabetes: A randomized, controlled study","volume":"44","author":"Vadini","year":"2020","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.biopsych.2026.06.006_bib76","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2174\/1567205016666190913155950","article-title":"A pilot study of exenatide actions in Alzheimer\u2019s disease","volume":"16","author":"Mullins","year":"2019","journal-title":"Curr Alzheimer Res"},{"key":"10.1016\/j.biopsych.2026.06.006_bib77","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.17219\/acem\/161734","article-title":"Evaluating the effects of glucagon-like peptide-1 receptor agonists on cognitive function in Alzheimer\u2019s disease: A systematic review and meta-analysis","volume":"32","author":"Bi","year":"2023","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.biopsych.2026.06.006_bib78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13195-024-01666-7","article-title":"evoke and evoke+: Design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic Alzheimer\u2019s disease","volume":"17","author":"Cummings","year":"2025","journal-title":"Alzheimers Res Ther"},{"key":"10.1016\/j.biopsych.2026.06.006_bib79","doi-asserted-by":"crossref","first-page":"E1314","DOI":"10.1152\/ajpendo.00137.2013","article-title":"Nucleus accumbens GLP-1 receptors influence meal size and palatability","volume":"304","author":"Dossat","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2026.06.006_bib80","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1186\/s13578-022-00914-3","article-title":"Activation of arcuate nucleus glucagon-like peptide-1 receptor-expressing neurons suppresses food intake","volume":"12","author":"Singh","year":"2022","journal-title":"Cell Biosci"},{"key":"10.1016\/j.biopsych.2026.06.006_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061965","article-title":"Gut peptide GLP-1 and its analogue, exendin-4, decrease alcohol intake and reward","volume":"8","author":"Shirazi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2026.06.006_bib82","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1006\/appe.2002.0500","article-title":"Memory for recent eating and its influence on subsequent food intake","volume":"39","author":"Higgs","year":"2002","journal-title":"Appetite"},{"key":"10.1016\/j.biopsych.2026.06.006_bib83","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.physbeh.2008.04.012","article-title":"Cognitive influences on food intake: The effects of manipulating memory for recent eating","volume":"94","author":"Higgs","year":"2008","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2026.06.006_bib84","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1467-9280.2008.02132.x","article-title":"Sensory-specific satiety is intact in amnesics who eat multiple meals","volume":"19","author":"Higgs","year":"2008","journal-title":"Psychol Sci"},{"key":"10.1016\/j.biopsych.2026.06.006_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133666","article-title":"Relationship between eating disturbance and dementia severity in patients with Alzheimer\u2019s disease","volume":"10","author":"Kai","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.biopsych.2026.06.006_bib86","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2020.604488","article-title":"Eating behavior in aging and dementia: The need for a comprehensive assessment","volume":"7","author":"Fostinelli","year":"2020","journal-title":"Front Nutr"},{"key":"10.1016\/j.biopsych.2026.06.006_bib87","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1177\/1533317516673155","article-title":"Eating behaviors and dietary changes in patients with dementia","volume":"31","author":"Cipriani","year":"2016","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"10.1016\/j.biopsych.2026.06.006_bib88","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/nprot.2006.116","article-title":"Morris water maze: Procedures for assessing spatial and related forms of learning and memory","volume":"1","author":"Vorhees","year":"2006","journal-title":"Nat Protoc"},{"key":"10.1016\/j.biopsych.2026.06.006_bib89","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/ijo.2012.91","article-title":"Liraglutide improves hippocampal synaptic plasticity associated with increased expression of Mash1 in ob\/ob mice","volume":"37","author":"Porter","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.biopsych.2026.06.006_bib90","doi-asserted-by":"crossref","first-page":"877","DOI":"10.3233\/JAD-143090","article-title":"The GLP-1 receptor agonist liraglutide improves memory function and increases hippocampal CA1 neuronal numbers in a senescence-accelerated mouse model of Alzheimer\u2019s disease","volume":"46","author":"Hansen","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2026.06.006_bib91","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejphar.2008.03.025","article-title":"GLP-1 agonists facilitate hippocampal LTP and reverse the impairment of LTP induced by beta-amyloid","volume":"587","author":"Gault","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib92","doi-asserted-by":"crossref","first-page":"8326","DOI":"10.1038\/s41598-021-87809-4","article-title":"Exendin-4 improves long-term potentiation and neuronal dendritic growth in vivo and in vitro obesity condition","volume":"11","author":"Wang","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.biopsych.2026.06.006_bib93","doi-asserted-by":"crossref","first-page":"661","DOI":"10.17219\/acem\/121007","article-title":"The role of GLP-1\/GIP receptor agonists in Alzheimer\u2019s disease","volume":"29","author":"Yu","year":"2020","journal-title":"Adv Clin Exp Med"},{"key":"10.1016\/j.biopsych.2026.06.006_bib94","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.neuropharm.2017.12.001","article-title":"Insulin-mediated synaptic plasticity in the CNS: Anatomical, functional and temporal contexts","volume":"136","author":"Ferrario","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.biopsych.2026.06.006_bib95","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1177\/193229680800200619","article-title":"Alzheimer\u2019s disease is type 3 diabetes\u2014evidence reviewed","volume":"2","author":"de la Monte","year":"2008","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108277","article-title":"Incretin-based drugs as potential therapy for neurodegenerative diseases: current status and perspectives","volume":"239","author":"Ferrari","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2026.06.006_bib97","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1205207","article-title":"Glucagon-like peptide 1 (GLP-1) receptor agonists in experimental Alzheimer\u2019s disease models: A systematic review and meta-analysis of preclinical studies","volume":"14","author":"Kong","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib98","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1096\/fj.06-7703com","article-title":"Amyloid beta oligomers induce impairment of neuronal insulin receptors","volume":"22","author":"Zhao","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/j.biopsych.2026.06.006_bib99","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1038\/nrn4019","article-title":"Hippocampal insulin resistance and cognitive dysfunction","volume":"16","author":"Biessels","year":"2015","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.006_bib100","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S1474-4422(14)70249-2","article-title":"Cognitive function in patients with diabetes mellitus: Guidance for daily care","volume":"14","author":"Koekkoek","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib101","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.3233\/JAD-159002","article-title":"Long acting intranasal insulin detemir improves cognition for adults with mild cognitive impairment or early-stage Alzheimer\u2019s disease dementia","volume":"45","author":"Claxton","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2026.06.006_bib102","doi-asserted-by":"crossref","first-page":"323","DOI":"10.3233\/JAD-2008-13309","article-title":"Intranasal insulin administration dose-dependently modulates verbal memory and plasma amyloid-beta in memory-impaired older adults","volume":"13","author":"Reger","year":"2008","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.biopsych.2026.06.006_bib103","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1001\/archneurol.2011.233","article-title":"Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: A pilot clinical trial","volume":"69","author":"Craft","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib104","article-title":"Glucagon-like peptide-1 (GLP-1) receptor agonists: Exploring their impact on diabetes, obesity, and cardiovascular health through a comprehensive literature review","volume":"16","author":"Hamed","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.biopsych.2026.06.006_bib105","doi-asserted-by":"crossref","first-page":"672","DOI":"10.3389\/fendo.2018.00672","article-title":"Pleiotropic effects of GLP-1 and analogs on cell signaling, metabolism, and function","volume":"9","author":"Rowlands","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.biopsych.2026.06.006_bib106","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3390\/ijms23020739","article-title":"GLP-1a: Going beyond traditional use","volume":"23","author":"Laurindo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.biopsych.2026.06.006_bib107","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coph.2016.08.007","article-title":"Novel developments in vagal afferent nutrient sensing and its role in energy homeostasis","volume":"31","author":"de Lartigue","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib108","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.physbeh.2007.07.003","article-title":"CCK(1) receptor is essential for normal meal patterning in mice fed high fat diet","volume":"92","author":"Donovan","year":"2007","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2026.06.006_bib109","doi-asserted-by":"crossref","first-page":"E898","DOI":"10.1152\/ajpendo.90796.2008","article-title":"Increased expression of receptors for orexigenic factors in nodose ganglion of diet-induced obese rats","volume":"296","author":"Paulino","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.biopsych.2026.06.006_bib110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.autneu.2003.11.001","article-title":"Receptor gene expression of glucagon-like peptide-1, but not glucose-dependent insulinotropic polypeptide, in rat nodose ganglion cells","volume":"110","author":"Nakagawa","year":"2004","journal-title":"Auton Neurosci"},{"key":"10.1016\/j.biopsych.2026.06.006_bib111","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/en.2006-0153","article-title":"Glucagon-like peptide-1 (GLP-1) receptors expressed on nerve terminals in the portal vein mediate the effects of endogenous GLP-1 on glucose tolerance in rats","volume":"148","author":"Vahl","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopsych.2026.06.006_bib112","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2982.2009.01317.x","article-title":"Receptor-mediated activation of gastric vagal afferents by glucagon-like peptide-1 in the rat","volume":"21","author":"Bucinskaite","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.1016\/j.biopsych.2026.06.006_bib113","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/bph.15603","article-title":"Reappraising the role of the vagus nerve in GLP-1-mediated regulation of eating","volume":"179","author":"Brierley","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.peptides.2020.170342","article-title":"Intestinal glucagon-like peptide-1 effects on food intake: Physiological relevance and emerging mechanisms","volume":"131","author":"Krieger","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/j.biopsych.2026.06.006_bib115","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.physbeh.2015.06.001","article-title":"Vagal mediation of GLP-1\u2019s effects on food intake and glycemia","volume":"152","author":"Krieger","year":"2015","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2026.06.006_bib116","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/j.biopsych.2026.06.006_bib117","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.physbeh.2012.02.017","article-title":"Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects","volume":"106","author":"Hayes","year":"2012","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2026.06.006_bib118","doi-asserted-by":"crossref","first-page":"R1479","DOI":"10.1152\/ajpregu.00356.2011","article-title":"The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1","volume":"301","author":"Hayes","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib119","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1210\/en.2005-0473","article-title":"Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice","volume":"146","author":"Talsania","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.biopsych.2026.06.006_bib120","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.brainres.2005.03.011","article-title":"The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway","volume":"1044","author":"Abbott","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2026.06.006_bib121","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.npep.2017.05.003","article-title":"Glucagon-like peptide-1 and insulin synergistically activate vagal afferent neurons","volume":"65","author":"Iwasaki","year":"2017","journal-title":"Neuropeptides"},{"key":"10.1016\/j.biopsych.2026.06.006_bib122","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.peptides.2011.12.009","article-title":"Exenatide and feeding: possible peripheral neuronal pathways","volume":"33","author":"Hunt","year":"2012","journal-title":"Peptides"},{"key":"10.1016\/j.biopsych.2026.06.006_bib123","doi-asserted-by":"crossref","first-page":"G671","DOI":"10.1152\/ajpgi.00348.2017","article-title":"Lixisenatide requires a functional gut-vagus nerve-brain axis to trigger insulin secretion in controls and type 2 diabetic mice","volume":"315","author":"Charpentier","year":"2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib124","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.semcdb.2023.02.004","article-title":"The gut-brain axis and cognitive control: A role for the vagus nerve","volume":"156","author":"Decarie-Spain","year":"2024","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib125","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1038\/s41467-018-04639-1","article-title":"Gut vagal sensory signaling regulates hippocampus function through multi-order pathways","volume":"9","author":"Suarez","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.biopsych.2026.06.006_bib126","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.bbi.2024.03.015","article-title":"Western diet consumption impairs memory function via dysregulated hippocampus acetylcholine signaling","volume":"118","author":"Hayes","year":"2024","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.biopsych.2026.06.006_bib127","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.physbeh.2010.12.003","article-title":"Western diet consumption and cognitive impairment: Links to hippocampal dysfunction and obesity","volume":"103","author":"Kanoski","year":"2011","journal-title":"Physiol Behav"},{"key":"10.1016\/j.biopsych.2026.06.006_bib128","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-8587(13)70125-6","article-title":"Diabetes drugs and neurological disorders: New views and therapeutic possibilities","volume":"2","author":"Patrone","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib129","doi-asserted-by":"crossref","first-page":"851","DOI":"10.5114\/aoms.2016.58928","article-title":"Obesity and inflammation: The linking mechanism and the complications","volume":"13","author":"Ellulu","year":"2017","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.biopsych.2026.06.006_bib130","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.3389\/fimmu.2018.02649","article-title":"Inflammatory links between high fat diets and diseases","volume":"9","author":"Duan","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib131","doi-asserted-by":"crossref","DOI":"10.1002\/cph4.70044","article-title":"Endotoxemia-induced inflammation in the absence of obesity is associated with decreased anxiety-like and impulsive behavior with no effect on learning and memory","volume":"15","author":"Klug","year":"2025","journal-title":"Compr Physiol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib132","article-title":"Adipose tissue in obesity-related inflammation and insulin resistance: Cells, cytokines, and chemokines","volume":"2013","author":"Makki","year":"2013","journal-title":"ISRN Inflamm"},{"key":"10.1016\/j.biopsych.2026.06.006_bib133","doi-asserted-by":"crossref","DOI":"10.4239\/wjd.v16.i10.108714","article-title":"Role of astrocytes in diabetic neuropathy: Review of their involvement in disease mechanisms","volume":"16","author":"Haris","year":"2025","journal-title":"World J Diabetes"},{"key":"10.1016\/j.biopsych.2026.06.006_bib134","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/s41392-023-01588-0","article-title":"Microglia in neurodegenerative diseases: Mechanism and potential therapeutic targets","volume":"8","author":"Gao","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.biopsych.2026.06.006_bib135","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1208\/s12248-017-0079-3","article-title":"Blood-brain barriers in obesity","volume":"19","author":"Rhea","year":"2017","journal-title":"AAPS J"},{"key":"10.1016\/j.biopsych.2026.06.006_bib136","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer\u2019s disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2026.06.006_bib137","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1038\/s41423-021-00757-x","article-title":"The blood-brain barrier in systemic infection and inflammation","volume":"18","author":"Galea","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib138","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","article-title":"Effect of dulaglutide on cognitive impairment in type 2 diabetes: An exploratory analysis of the REWIND trial","volume":"19","author":"Cukierman-Yaffe","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib139","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2337\/dc19-0749","article-title":"PIONEER 1: Randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes","volume":"42","author":"Aroda","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.biopsych.2026.06.006_bib140","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S2213-8587(17)30013-X","article-title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): A double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial","volume":"5","author":"Sorli","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.biopsych.2026.06.006_bib141","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0140-6736(23)01127-3","article-title":"Efficacy and safety of once-daily oral semaglutide 25 mg and 50 mg compared with 14 mg in adults with type 2 diabetes (PIONEER PLUS): A multicentre, randomised, phase 3b trial","volume":"402","author":"Aroda","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2026.06.006_bib142","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.70063","article-title":"Sex differences in the efficacy of glucagon-like peptide-1 receptor agonists for weight reduction: A systematic review and meta-analysis","volume":"17","author":"Yang","year":"2025","journal-title":"J Diabetes"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326013442?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322326013442?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:30:08Z","timestamp":1791055808000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322326013442"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":142,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0006322326013442"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.06.006","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-Like Peptide-1 Signaling in Learning and Memory: Evidence, Mechanisms, and Therapeutic Implications","name":"articletitle","label":"Article Title"},{"value":"Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopsych.2026.06.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Society of Biological Psychiatry.","name":"copyright","label":"Copyright"}]}}